# Centrix, Inc. – FDA Inspection, Jan 31, 2017

Source: https://www.keypedia.com/records/fda_inspections/centrix-inc/e0d38e71-0f34-4622-9a42-46556626a966
Source feed: FDA_Inspections

> FDA inspection 1000207 of Centrix, Inc., January 31, 2017. Classification: Voluntary Action Indicated (VAI). 8 citations under 21 CFR part 211. Form 483 issued. 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1000207
- Company Name: Centrix, Inc.
- Inspection Date: 2017-01-31
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Unapproved and Misbranded Drugs
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 8

## Related Documents

- [FDA Inspection 1163529 - 2022-03-02](https://www.keypedia.com/records/fda_inspections/centrix-inc/6ab4d47b-2e29-4fcc-9434-454540864b26)
- FDA Inspection 839521 - 2013-06-27
- FDA Inspection 681956 - 2010-09-24

## Related Officers

- Issuing Officer

Company: https://www.keypedia.com/companies/centrix-inc/f67d1354-9497-4a39-9320-0be314e62568

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
